MLVA-typing on Streptococcus pneumoniae serotype 1 isolated from meningitis cases in Niger before the introduction of PCV-13 revealed a low genetic diversity

Trans R Soc Trop Med Hyg. 2015 Jul;109(7):477-80. doi: 10.1093/trstmh/trv033. Epub 2015 May 1.

Abstract

Background: Serotype 1 was the most prevalent pneumococcal meningitis serotype encountered in Niger over the period 2003-2011 (pre-vaccination era), accounting for 45.3% of infections.

Methods: Multiple locus VNTR analysis (MLVA) was used to create a genotypic snapshot of a representative subset of the pneumococcal population of serotype 1.

Results: MLVA using 16 markers revealed a homogeneous genetic background of pneumococci serotype 1 from Niger, which clustered with few serotype 1 pneumococci from some African countries, while other African countries displayed different clonal complexes. DNA from Niger and from other African countries were different from pneumococci serotype 1 from European countries.

Conclusions: MLVA-typing revealed a low genetic diversity among pneumococci serotype 1 from meningitis cases in Niger in the pre-vaccination era.

Keywords: Genetic diversity; Multiple locus VNTR analysis; Niger; Serotype 1; Streptococcus pneumoniae.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Variation
  • Genotype
  • Humans
  • Meningitis / microbiology*
  • Minisatellite Repeats / genetics
  • Multilocus Sequence Typing / methods*
  • Niger / epidemiology
  • Pneumococcal Infections / microbiology*
  • Pneumococcal Infections / prevention & control
  • Pneumococcal Vaccines / therapeutic use
  • Prevalence
  • Serotyping
  • Streptococcus pneumoniae / classification
  • Streptococcus pneumoniae / genetics*
  • Streptococcus pneumoniae / isolation & purification

Substances

  • 13-valent pneumococcal vaccine
  • Pneumococcal Vaccines